期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
改变表观遗传修饰和供体细胞代谢状态可提高犬-猪异种克隆胚胎的发育效率
1
作者 闫艳霞 张雨涵 +1 位作者 吴珍芳 李紫聪 《遗传》 北大核心 2025年第12期1365-1376,共12页
为了探索能提高犬体细胞克隆效率的新方法,本研究比较了糖酵解促进剂PS48和表观遗传修饰剂(DNA甲基化酶抑制剂RG108和组蛋白去乙酰化酶抑制剂Scriptaid)的不同处理浓度和时间对犬-猪异种体细胞核移植(interspecies somatic cell nuclear... 为了探索能提高犬体细胞克隆效率的新方法,本研究比较了糖酵解促进剂PS48和表观遗传修饰剂(DNA甲基化酶抑制剂RG108和组蛋白去乙酰化酶抑制剂Scriptaid)的不同处理浓度和时间对犬-猪异种体细胞核移植(interspecies somatic cell nuclear transfer,iSCNT)胚胎发育效率的影响。结果显示:(1) 5μmol/L PS48处理犬耳成纤维细胞(canine ear fibroblasts,cEFs)和犬脂肪间充质干细胞(canine adipose tissue-derived mesenchymal stem cells,cAd-MSCs) 24 h显著增强了其后续iSCNT胚胎的发育能力,PS48处理cEFs组的iSCNT胚胎的卵裂率、4-细胞期率和8-细胞期率均显著高于对照组(46.90±1.64%vs 13.30±1.61%,32.30±1.55%vs 8.26±0.88%,10.62±1.68%vs 5.50±0.84%;P<0.05),PS48处理cAd-MSCs组的iSCNT胚胎的卵裂率和4-细胞期率显著高于对照组(49.51±3.00%vs 31.25±2.73%,26.21±2.08%vs 15.18±1.58%;P<0.05);(2) 20μmol/L RG108处理cEFs和cAd-MSCs 48 h对iSCNT胚胎发育效率无显著影响,0 nmol/L、400 nmol/L、500 nmol/L和600 nmol/L Scriptaid分别处理cEFs和cAd-MSCs 24 h对iSCNT胚胎发育效率无显著影响;(3) 20μmol/L RG108处理两种供体细胞来源iSCNT胚胎对其发育有显著促进作用(P<0.05),500 nmol/L Scriptaid处理cEFs来源的iSCNT胚胎16 h可显著提高其卵裂率和4-细胞期率(23.08±2.94%vs 9.47±1.70%,18.68±3.25%vs 6.32±1.07%;P<0.05)。本研究建立了能显著提高犬-猪iSCNT胚胎发育效率的新方法,有助于促进犬体细胞克隆技术的应用和发展。 展开更多
关键词 供体细胞代谢 表观遗传修饰 犬克隆 体细胞核移植 PS48 RG108 Scriptaid
在线阅读 下载PDF
Current research status of tumor cell biomarker detection 被引量:2
2
作者 Liying Jiang Xinyi Lin +6 位作者 Fenghua Chen Xiaoyun Qin yanxia yan Linjiao Ren Hongyu Yu Lingqian Chang ang Wang 《Microsystems & Nanoengineering》 SCIE EI CSCD 2023年第5期17-34,共18页
With the annual increases in the morbidity and mortality rates of tumors,the use of biomarkers for early diagnosis and real-time monitoring of tumor cells is of great importance.Biomarkers used for tumor cell detectio... With the annual increases in the morbidity and mortality rates of tumors,the use of biomarkers for early diagnosis and real-time monitoring of tumor cells is of great importance.Biomarkers used for tumor cell detection in body fluids include circulating tumor cells,nucleic acids,protein markers,and extracellular vesicles.Among them,circulating tumor cells,circulating tumor DNA,and exosomes have high potential for the prediction,diagnosis,and prognosis of tumor diseases due to the large amount of valuable information on tumor characteristics and evolution;in addition,in situ monitoring of telomerase and miRNA in living cells has been the topic of extensive research to understand tumor development in real time.Various techniques,such as enzyme-linked immunosorbent assays,immunoblotting,and mass spectrometry,have been widely used for the detection of these markers.Among them,the detection of tumor cell markers in body fluids based on electrochemical biosensors and fluorescence signal analysis is highly preferred because of its high sensitivity,rapid detection and portable operation.Herein,we summarize recent research progress in the detection of tumor cell biomarkers in body fluids using electrochemical and fluorescence biosensors,outline the current research status of in situ fluorescence monitoring and the analysis of tumor markers in living cells,and discuss the technical challenges for their practical clinical application to provide a reference for the development of new tumor marker detection methods. 展开更多
关键词 DIAGNOSIS MORTALITY DISEASES
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部